| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |